| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2024 | CENTREXION THERAPEUTICS CORP | 1 BOSTON PL STE 3520 | BOSTON | MA | 02108-4401 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 3 | NIH | 12/1/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | CENTREXION THERAPEUTICS CORP | 1 BOSTON PL STE 3520 | BOSTON | MA | 02108-4401 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 001 | 3 | NIH | 5/28/2025 | $0 |
| | 2025 | 2024 | CENTREXION THERAPEUTICS CORP | 1 BOSTON PL STE 3520 | BOSTON | MA | 02108-4401 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 3 | NIH | 1/16/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,539,507 ) |
| | 2024 | 2024 | CENTREXION THERAPEUTICS CORP | 200 STATE ST STE 6 | BOSTON | MA | 02109-2696 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 001 | 3 | NIH | 4/9/2024 | $353,950 |
| | 2024 | 2024 | CENTREXION THERAPEUTICS CORP | 200 STATE ST STE 6 | BOSTON | MA | 02109-2696 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 3 | NIH | 1/29/2024 | $3,185,557 |
| | 2024 | 2021 | CENTREXION THERAPEUTICS CORP | 1 BOSTON PL STE 3520 | BOSTON | MA | 02108-4401 | SUFFOLK | USA | UG3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 1 | NIH | 1/9/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,072,761 ) |
| | 2023 | 2023 | CENTREXION THERAPEUTICS CORP | 200 STATE ST | BOSTON | MA | 02109-2696 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 001 | 2 | NIH | 8/23/2023 | $400,000 |
| | 2023 | 2023 | CENTREXION THERAPEUTICS CORP | 200 STATE ST | BOSTON | MA | 02109-2696 | SUFFOLK | USA | UH3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 2 | NIH | 2/26/2023 | $2,672,761 |
| | 2023 | 2021 | CENTREXION THERAPEUTICS CORP | 200 STATE ST | BOSTON | MA | 02109-2696 | SUFFOLK | USA | UG3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 1 | NIH | 5/19/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,050,367 ) |
| | 2021 | 2021 | CENTREXION THERAPEUTICS CORPORATION | 200 STATE ST FL 6 | BOSTON | MA | 02109 | SUFFOLK | USA | UG3NS123965 | Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | 000 | 1 | NIH | 9/23/2021 | $2,050,367 |
|
|
